ZORYVE cream 0.05% provides rapid and effective relief of mild to moderate atopic dermatitis in children ages 2 to 5 and is safe and well tolerated Once-daily, steroid-free cream can be used anywhere ...

Credit: Acrutis. Zoryve cream 0.05% is a once-daily, steroid-free cream for atopic dermatitis in patients aged 2 to 5 years. Zoryve cream 0.05% is expected to be available by the end of October 2025.

The once-daily, steroid-free cream can be used anywhere on the body for treatment and for any duration, according to Arcutis. FDA approved roflumilast cream 0.05% (Zoryve) for children aged 2–5 years ...

Roflumilast cream 0.05% showed durable efficacy and long-term tolerability in children aged 2 to 5 years with atopic dermatitis over 56 weeks. The cream demonstrated high application-site tolerability ...

The application is for children aged 2 to 5 years with mild-to-moderate atopic dermatitis. On February 26, 2025, roflumilast cream 0.05% (Zoryve; Arcutis Biotherapeutics) took a step forward on the ...

ZORYVE cream 0.05% provided meaningful disease clearance and rapid reduction in itch in pivotal trials Roflumilast cream was well tolerated and demonstrated a favorable safety and tolerability profile ...